JAMA Neurology
Randomized Controlled Trial
Oral Celecoxib and Ciprofloxacin Slow Functional Decline in ALS
A phase 2b trial shows the fixed-dose combination is safe and reduces the risk of severe complications over 18 months in early-stage ALS.
JAMA Neurology
Cohort Study
Suicidality at Focal Epilepsy Diagnosis Predicts Treatment Resistance
Adults expressing suicidality when diagnosed with focal epilepsy face a nearly threefold higher risk of failing antiseizure medications.